FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 4 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,686,000 | -26.6% | 506,214 | -33.0% | 0.12% | -41.9% |
| Q3 2019 | $2,298,000 | +27.7% | 755,998 | 0.0% | 0.20% | +25.3% |
| Q2 2019 | $1,799,000 | -36.5% | 755,998 | 0.0% | 0.16% | -25.8% |
| Q1 2019 | $2,835,000 | +4.5% | 755,998 | 0.0% | 0.21% | -9.4% |
| Q4 2018 | $2,714,000 | +610.5% | 755,998 | +980.0% | 0.24% | +552.8% |
| Q3 2014 | $382,000 | – | 70,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $24,530,000,000 | 3.64% |
| Opaleye Management Inc. | 950,000 | $4,873,000 | 1.39% |
| DSC Advisors, L.P. | 1,187,604 | $6,092,000 | 1.28% |
| DAFNA Capital Management LLC | 335,500 | $1,721,000 | 0.84% |
| Vivo Capital, LLC | 855,000 | $4,386,000 | 0.62% |
| Stonepine Capital Management, LLC | 129,756 | $666,000 | 0.36% |
| Eversept Partners, LP | 107,500 | $551,475 | 0.26% |
| Tekla Capital Management LLC | 930,398 | $4,773,000 | 0.19% |
| Perceptive Advisors | 1,117,324 | $5,732,000 | 0.16% |
| Crestline Management, LP | 217,670 | $1,117,000 | 0.14% |